Viewing Study NCT05299658


Ignite Creation Date: 2025-12-25 @ 12:13 AM
Ignite Modification Date: 2025-12-25 @ 10:14 PM
Study NCT ID: NCT05299658
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-19
First Post: 2022-03-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: An Open-Label Extension for the Phase 2 Study in Early Symptomatic Amyotrophic Lateral Sclerosis Patients on Stable Background Therapy to Assess Bioenergetic Catalysis With CNM-Au8 to Slow Disease Progression in ALS
Sponsor: Clene Nanomedicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module